Role of Adenosine A2A Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease

被引:29
|
作者
Tebano, Maria Teresa [1 ]
Martire, Alberto [1 ]
Chiodi, Valentina [1 ]
Ferrante, Antonella [1 ]
Popoli, Patrizia [1 ]
机构
[1] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy
来源
THESCIENTIFICWORLDJOURNAL | 2010年 / 10卷
关键词
adenosine A(2A) receptors; BDNF; synaptic transmission; hippocampus; Huntington's disease; TRK NEUROTROPHIN RECEPTORS; PROTEIN-COUPLED RECEPTORS; LONG-TERM POTENTIATION; HIGHER-ORDER OLIGOMERS; MESSENGER-RNA; MOTOR-NEURONS; LASTING POTENTIATION; HIPPOCAMPAL-NEURONS; RECOGNITION MEMORY; TRANSGENIC MICE;
D O I
10.1100/tsw.2010.164
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
In the last few years, accumulating evidence has shown the existence of an important cross-talk between adenosine A(2A) receptors (A(2A)Rs) and brain-derived neurotrophic factor (BDNF). Not only are A(2A)Rs involved in the mechanism of transactivation of BDNF receptor TrkB, they also modulate the effect of BDNF on synaptic transmission, playing a facilitatory and permissive role. The cAMP-PKA pathway, the main transduction system operated by A(2A)Rs, is involved in such effects. Furthermore, a basal tonus of A(2A)Rs is required to allow the regulation of BDNF physiological levels in the brain, as demonstrated by the reduced protein levels measured in A(2A)Rs KO mice. The crucial role of adenosine A(2A)Rs in the maintenance of synaptic functions and BDNF levels will be reviewed here and discussed in the light of possible implications for Huntington's disease therapy, in which a joint impairment of BDNF and A(2A)Rs seems to play a pathogenetic role.
引用
收藏
页码:1768 / 1782
页数:15
相关论文
共 24 条
  • [1] Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease
    Popoli, Patrizia
    Blum, David
    Martire, Alberto
    Ledent, Catherine
    Ceruti, Stefania
    Abbracchio, Maria P.
    PROGRESS IN NEUROBIOLOGY, 2007, 81 (5-6) : 331 - 348
  • [2] Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease
    R. L. Potenza
    M. T. Tebano
    A. Martire
    M. R. Domenici
    R. Pepponi
    M. Armida
    A. Pèzzola
    L. Minghetti
    P. Popoli
    Purinergic Signalling, 2007, 3 : 333 - 338
  • [3] Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease
    Potenza, R. L.
    Tebano, M. T.
    Martire, A.
    Domenici, M. R.
    Pepponi, R.
    Armida, M.
    Pezzola, A.
    Minghetti, L.
    Popoli, P.
    PURINERGIC SIGNALLING, 2007, 3 (04) : 333 - 338
  • [4] Effects of chronic adenosine A2A receptor blockade on Huntington's disease pathophysiology
    Mievis, Stephane
    Duru, Cecile
    Simonin, Clemence
    Dhaenens, Claire-Marie
    Burnouf, Sylvie
    Vassart, Gilbert
    Buee, Luc
    Richard, Florence
    Genin, Michael
    Sablonniere, Bernard
    Durr, Alexandra
    Bachoud-Levi, Anne-Catherine
    Krystkowiak, Pierre
    Ledent, Catherine
    Blum, David
    PURINERGIC SIGNALLING, 2010, 6 : 137 - 137
  • [5] Adenosine A2A receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus
    Tebano, M. T.
    Martire, A.
    Potenza, R. L.
    Gro, C.
    Pepponi, R.
    Armida, M.
    Domenici, M. R.
    Schwarzschild, M. A.
    Chen, J. F.
    Popoli, P.
    JOURNAL OF NEUROCHEMISTRY, 2008, 104 (01) : 279 - 286
  • [6] The role of adenosine A2A receptors in Alzheimer?s disease and tauopathies
    Launay, Agathe
    Nebie, Ouada
    Shankara, Jhenkruthi Vijaya
    Lebouvier, Thibaud
    Buee, Luc
    Faivre, Emilie
    Blum, David
    NEUROPHARMACOLOGY, 2023, 226
  • [7] A critical evaluation of adenosine A2A receptors as potentially "Druggable" targets in Huntington's disease
    Popoli, Patrizia
    Blum, David
    Domenici, Maria Rosaria
    Burnouf, Sylvie
    Chern, Yijuang
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (15) : 1500 - 1511
  • [8] Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias
    Calon, F
    Dridi, M
    Hornykiewicz, O
    Bédard, PJ
    Rajput, AH
    Di Paolo, T
    BRAIN, 2004, 127 : 1075 - 1084
  • [9] Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia
    Pinna, Annalisa
    Serra, Marcello
    Morelli, Micaela
    Simola, Nicola
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (08) : 1273 - 1286
  • [10] Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia
    Annalisa Pinna
    Marcello Serra
    Micaela Morelli
    Nicola Simola
    Journal of Neural Transmission, 2018, 125 : 1273 - 1286